Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "catalyspacific.com"

89
Business Relations
87
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 89
From Domain Role To Domain Path Aktionen
/vc-firms/catalys-pacific
/renalys/
/lengste-haret-i-india-www-parinka-chopra-com-hardcore-porn-tube-free-hot-sex/
/perspective/hillevax-closes-135-million-crossover-financing-to-advance-clinical-stage-norovirus-vaccine-candidate
/perspective/phathom-pharmaceuticals-announces-positive-topline-results-from-phalcon-ee-pivotal-phase-3-erosive-esophagitis-trial
/perspective/aculys-pharma-closes-us60-million-series-a-financing-led-by-softbank-vision-fund-2
/perspective/catalys-pacific-calls-for-economical-disengagement-from-russian-industry
/perspective/catalys-pacific-launches-kirilys-therapeutics-as-a-multi-asset-precision-oncology-company
/perspective/aculys-pharma-closes-us24-million-series-b-financing
/perspective/aculys-pharma-closes-us24-million-series-b-financing
/perspective/phathom-pharmaceuticals-announces-fda-approval-of-voquezna-triple-pak-vonoprazan-amoxicillin-clarithromycin-and-voquezna-dual-pak-vonoprazan-amoxicillin-for
/perspective/aculys-pharma-initiates-a-phase-3-clinical-study-of-a-diazepam-nasal-spray-an-antiepileptic-drug-for-the-treatment-of-epileptic-seizures
/perspective/pathalys-pharma-raises-150-million-in-secured-product-financing-and-equity-led-by-abingworth-forms-strategic-collaboration-with-launch-therapeutics-to-advance-upacicalcet-through-pivotal-phase-3-stu
/perspective/transposon-announces-final-results-from-a-phase-2-study-of-its-line-1-reverse-transcriptase-inhibitor-tpn-101-for-the-treatment-of-progressive-supranuclear-palsy-and-interim-results-from-a-phase-2-stu
/perspective/inventiva-announces-positive-results-from-the-phase-ii-legend-proof-of-concept-study-combining-lanifibranor-with-empagliflozin-in-patients-with-mash-nash-and-t2d
/perspective/inventiva-announces-positive-results-from-the-phase-ii-legend-proof-of-concept-study-combining-lanifibranor-with-empagliflozin-in-patients-with-mash-nash-and-t2d
/perspective/pathalys-pharma-secures-105-million-series-b-financing
/perspective/arialys-therapeutics-announces-first-participants-dosed-in-a-phase-1-clinical-trial-of-art5803-a-precision-medicine-for-the-treatment-of-autoimmune-neuropsychiatric-diseases
/perspective/aculys-pharma-announces-positive-results-in-japan-phase-iii-clinical-trial-of-pitolisant-in-patients-with-obstructive-sleep-apnea-syndrome-osas
/perspective/aculys-pharma-signs-4-4-billion-yen-series-c-funding-round-agreement